| Biodegradable polymeric particles encapsulating an active agent, pharmaceutical … |
2022-6-22 |
2022-10-20 |
|
| Therapeutic agent effectiveness and its route of administration |
2022-2-22 |
2022-4-01 |
|
| Coronavirus immunogenic t cell epitope compositions and uses thereof |
2021-7-12 |
2022-1-20 |
|
| Coronavirus immunogenic compositions and uses thereof |
2021-6-09 |
2022-7-12 |
2022-7-12 |
| Rapid and prolonged immunologic-therapeutic |
2021-3-28 |
2021-10-12 |
2021-10-12 |
| Zika and flavivirus immunogenic compositions and their use |
2021-3-05 |
2021-9-10 |
|
| IMMUNOGENIC COMPOSITIONS AGAINST CORONAVIRUS AND USES THEREOF |
2021-2-17 |
2022-5-11 |
|
| Coronavirus immunogenic compositions and uses thereof |
2021-2-12 |
2021-8-26 |
|
| T-cell inducing vaccine composition combinations and uses thereof |
2020-10-01 |
2020-11-30 |
|
| Immunizations of avians by administration of non-replicating vectored vaccines |
2020-7-10 |
2020-10-29 |
|
| Broad and long-lasting influenza vaccine |
2020-4-06 |
2020-10-08 |
|
| Broad and long-lasting influenza vaccine |
2020-4-06 |
2022-2-16 |
|
| Rapid and sustained immunological treatment |
2019-3-05 |
2021-10-06 |
2021-10-06 |
| Peptide pharmaceuticals for treatment of NASH and other disorders |
2019-1-03 |
2023-1-03 |
2023-1-03 |
| Targets and compositions for use in decontamination, immunoprophylaxis, and … |
2018-5-14 |
2019-2-14 |
|
| Methods and compositions for viral vectored gnrh vaccines to control … |
2017-11-09 |
2018-5-17 |
|
| Compositions and combinations of organophosphorus bioscavengers and hyaluronan- … |
2014-9-08 |
2015-1-15 |
|
| Methods and compositions for viral vectored vaccines |
2014-9-05 |
2016-4-07 |
|
| Recombinant Butyrylcholinesterases and Truncates Thereof |
2014-4-03 |
2014-8-07 |
|
| Immunization of avians by mucosal administration of non-replicating vectored … |
2011-3-25 |
2011-11-03 |
|
| Anthrax vaccine formulation and uses thereof |
2009-10-02 |
2017-2-15 |
2017-2-15 |
| Intranasal administration of receptor-binding ligands or genes encoding such … |
2009-6-03 |
2011-3-23 |
|
| Stable vaccine compositions and methods of use |
2009-1-22 |
2010-7-29 |
|
| Stable vaccine compositions and methods of use |
2009-1-22 |
2010-7-22 |
|
| Long half-life recombinant butyrylcholinesterase |
2007-8-02 |
2014-2-20 |
2014-2-20 |
| Method for assaying antigens |
2007-4-12 |
2013-7-18 |
2013-7-18 |
| System for rapid production of high-titer and replication-competent adenovirus- … |
2006-5-23 |
2008-3-19 |
|
| Production of hSA-linked butyrylcholinesterases in transgenic mammals |
2006-4-10 |
2006-11-09 |
|